A Functional Hot Spot for Antigen Recognition in a Superagonist TCR/MHC Complex  by Degano, Massimo et al.
Immunity, Vol. 12, 251±261, March, 2000, Copyright ª 2000 by Cell Press
A Functional Hot Spot for Antigen Recognition
in a Superagonist TCR/MHC Complex
of the T cell. Strong agonist self-ligands result in nega-
tive selection, so that self-reactive T cells are not en-
countered in the peripheral circulation. However, some
Massimo Degano,*§ K. Christopher Garcia,*k
Vasso Apostolopoulos,* Markus G. Rudolph,*
Luc Teyton,² and Ian A. Wilson*³
*Department of Molecular Biology and altered peptide ligands (APLs) that mimic self-antigens
can activate resting T cell clones and have been impli-Skaggs Institute for Chemical Biology
²Department of Immunology cated in the pathogenesis of certain autoimmune dis-
eases, such as multiple sclerosis, through a mechanismThe Scripps Research Institute
La Jolla, California 92037 of molecular mimicry (Oldstone, 1987; WuÈ cherpfennig
and Strominger, 1995), where a foreign pathogen epi-
tope, with often only minor sequence homology to a
self-antigen, causes T cell clonal expansion to the selfSummary
antigen.
Here, we describe the structural consequences of theA longstanding question in T cell receptor signaling is
recognition of a weak agonist versus a remarkablyhow structurally similar ligands, with similar affinities,
strong agonist by a single TCR. Mutation of naturallycan have substantially different biological activity. The
occurring peptide antigens at their TCR-contacting resi-crystal structure of the 2C TCR complex of H-2Kb with
dues usually results in a lower potency ligand, thus con-superagonist peptide SIYR at 2.8 AÊ elucidates a struc-
verting the APL to a partial agonist or antagonist. Whattural basis for TCR discrimination of altered peptide
is not at all clear is how substantially increased bioactiv-ligands. The difference in antigen potency is modu-
ity can be obtained from apparently subtle alterationslated by two cavities in the TCR combining site, formed
of peptide ligands with highly similar affinities.mainly by CDRs 3a, 3b, and 1b, that complement cen-
The three-dimensional structure of a complex be-trally located peptide residues. This ªfunctional hot
tween the murine 2C TCR and a self-pMHC (H-2Kb/dEV8)spotº allows the TCR to finely discriminate amongst
previously showed that a structural plasticity in the bind-energetically similar interactions within different li-
ing interface enabled productive interaction with thegands for those in which the peptide appropriately
pMHC through induced fit in the complementarity-stabilizes the TCR/pMHC complex and provides a new
determining region (CDR) loops (Garcia et al., 1998). Thestructural perspective for understanding differential
question remains as to whether agonist and antagonistsignaling resulting from T cell cross-reactivity.
ligands exert their different effects on T cell activation
by inducing specific conformational changes in the TCR
Introduction that can be related to different signaling outcomes in-
side the T cell; the different potencies of agonist and
T lymphocytes identify foreign pathogens through the antagonist ligands have been correlated with different
interaction of the clonotypic ab T cell receptor (TCR) phosphorylation states of the CD3 z chain (Sloan-Lan-
with peptide antigens bound to class I or class II major caster and Allen, 1996). In vitro studies with soluble TCR
histocompatibility complex (MHC) molecules (Zinkerna- and pMHC molecules have shown the inadequacy of T
gel and Doherty, 1974). The recognition of peptide-MHC cell activation models that are solely based on thermo-
ligands (pMHCs) by the ab TCR is followed by phosphor- dynamic equilibrium (i.e., affinity) considerations; rather,
ylation of CD3 z chains, which in turn leads to activation a stronger correlation is found with the kinetic stability,
of multiple intracellular signaling pathways in the T cell or half-life, of the TCR/pMHC complexes (Savage et al.,
(Izquierdo Pastor et al., 1995). Agonist peptides are ca- 1999). Recently, crystallographic data have shown that
pable of inducing full activation of the cell-mediated minimal structural differences arise between agonist
immune response, causing a hierarchical series of and antagonist TCR ligands, which have similar affinities
events, such as cytokine secretion, acid release, calcium (Ding et al., 1999). Here, we describe the opposite end
flux, and, ultimately, proliferation of T cells (Weiss and of the spectrum, the structural differences between a
Littman, 1994). Suboptimal ligands can still lead to a superagonist and its weak agonist counterpart.
partial activation of the T cell (Kersh and Allen, 1996;
Rabinowitz et al., 1996); hence, engagement of the TCR Results
can lead to a variety of outcomes depending on the
pMHC. Ligands that are weakly reactive, or weak ago- High Apparent Stability of 2C/H-2Kb/SIYR, as Judged
nists, are thought to drive the thymic positive selection by Native Gel Electrophoresis
process and later deliver signals for peripheral survival The SIYR sequence (SIYRYYGL) is highly related (67%
similarity, 33% identity) to the weak agonist dEV8
³ To whom correspondence should be addressed (e-mail: wilson@ (EQYKFYSV) (Tallquist et al., 1996), whose potency is
scripps.edu). approximately 105-fold weaker (Figures 1A and 1B), in
§ Present address: Structural Biology Laboratory, Sincrotrone Tri- which only the probable TCR-contacting residues at P4
este Elettra, 34012 Basovizza (TS), Italy.
and P7 are different. Although the limited range of pro-k Present address: Departments of Microbiology and Immunobiol-
tein concentrations used for the SPR experiments (Fig-ogy, and Structural Biology, Stanford University School of Medicine,
Stanford, California 94305. ure 1B) are not suited to extract precise Kd values for
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Table 1. Data Collection and Refinement Statistics
Data Collection and Processing
Resolution range (AÊ ) 50.0±2.7
Number of unique reflections (I . 2 2s(I)) 52,209
Redundancy 4.5
,I/s(I). 20.3 (2.9)
Completeness (%) 83.9 (93.0)
Rsym 0.089 (0.389)
Wilson B (AÊ 2) 62.4
Refinement Results
Resolution range (AÊ ) 50.0±2.7
Number of reflections (F . 0) 52,177
Effective resolution (AÊ ) 2.8
Anisotropic Correction (AÊ 2) B11 5 7.5, B22 5 231.4, B33 5 23.9
Rcryst 0.29
Rfree 0.34
Rmsd bonds (AÊ ) 0.009
Rmsd angles (8) 1.64
Rmsd improper angles (8) 0.86
Rmsd bonded B factors (AÊ 2) 1.51
Average Temperature Factors (AÊ 2)
TCR MHC Peptide
Molecule 1 44.0 39.6 22.5
Molecule 2 105.6 58.5 53.3
Real Space Correlation Coefficients
TCR MHC Peptide
Molecule 1 0.85 6 0.07 0.86 6 0.06 0.88 6 0.02
Molecule 2 0.61 6 0.20 0.80 6 0.09 0.76 6 0.05
Values between parentheses refer to the resolution range 2.8±2.7 AÊ .
Rsym 5 ShSijIi(h) 2 ,I(h).j/ShI(h), where Ii(h) is the ith measurement of the h reflection, and ,I(h). is the average value of the reflection intensity.
Effective resolution: the resolution at which the number of measured reflections with F . 2s(F), would constitute a 100% complete data set
(Jones et al., 1991).
Rcryst 5 SjjFobsj 2 jFcalcjj/SFobs, where Fobs and Fcalc are the structure factor amplitudes derived from the measured intensities and the model
coordinates, respectively. For Rfree, the value was calculated with 1,316 randomly selected reflections (2%) that were excluded from all stages
of refinement.
Real space correlation coefficient: correlation coefficient from the convolution between a sA-weighted, annealed 2Fo-Fc 10% omit electron
density map and the final model, reported as average value 6 standard deviation (Jones et al., 1991).
the respective interactions, it is clear that the huge differ- be analogous to the ability of membrane-bound com-
plexes to amplify small stability differences due to theence in biological potency of the peptides is not repre-
sented by an equivalent difference in affinity of the ter- restrictions imposed by 2-D lateral diffusion (Dustin et
al., 1996). This enhanced complex formation is morenary complexes. Rather, the affinities and kinetic rate
constants of the soluble TCR/pMHC interactions are consistent with recent T cell receptor clustering models,
demonstrating that potent agonist ligands are most ef-remarkably similar (Table 2; Garcia et al., 1997). Interest-
ingly, we found that the ªapparentº affinity of soluble fective at clustering the TCR/pMHC complexes in the
activated core of the T cell ªsynapseº with antigen-pre-2C TCR with H-2Kb/SIYR is significantly greater than with
H-2Kb/dEV8, as qualitatively analyzed by band-shifting senting cells (Grakoui et al., 1999). As little as a 3-fold
difference in the expression level of a single pMHC li-using nondenaturing native gel electrophoresis. As can
be seen from Figure 1C, the complex band (marked by gand on the cell surface is sufficient to result in negative
rather than positive selection (Garcia et al., 1997; Dela-an asterisk in lane 3) of 2C/H-2Kb/SIYR is reinforced
relative to the equivalent band of the 2C/H-2Kb/dEV8 ney et al., 1998). Thus, the small half-life differences
seen for the complexes with agonist and antagonistcomplex in lane 1. At the same time, the intensity of the
Kb band, when 2C is added, is diminished more strongly ligands using soluble molecules may be amplified by the
high local concentrations and the restricted 2-D lateralupon complex formation with SIYR (Figure 1C, compare
lanes 3 and 4) relative to the binding of 2C to H-2Kb/ diffusion of molecules on the cell surface (Dustin et al.,
1996), which is related to the conditions of the nativedEV8 (compare lanes 1 and 2).
Thus, this preferential complex formation of 2C with gel experiment. How then is this effect manifested in
the TCR/pMHC interface?H-2Kb/SIYR, as seen on native gels and biological
assays (Figures 1A and 1C), is not solely correlated with
the overall binding free energies of isolated recombinant Crystal Structure of a TCR Complex
with a Superagonist Ligandmolecules in solution. Since the ªcage-effectº in gels
leads to molecular crowding and, thus, increases the In order to understand the TCR recognition of a superag-
onist ligand, we have determined the crystal structureeffective concentration of the proteins, this effect may
Crystal Structure of a TCR Superagonist Complex
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to 2.8 AÊ resolution (Table 1; see below) of the murine
2C TCR (Kranz et al., 1984) in complex with the self-MHC
molecule H-2Kb, and the SIYR peptide, that displays
half maximal activity (EC50) at a concentration of 10 pM
(Figure 1; Table 2) (Udaka et al., 1996). The overall struc-
ture of the 2C/Kb/SIYR complex is similar to the pre-
viously reported structures of class I±restricted TCR/
pMHC complexes (Figure 2) (Garboczi et al., 1996; Gar-
cia et al., 1996, 1998; Ding et al., 1998, 1999; Teng et al.,
1998) and the recent class II±restricted pMHC complex
(Reinherz et al., 1999). The variable domains of the 2C
a and b chain contact the pMHC antigen via their CDR
loops, with an approximately diagonal orientation
across the MHC surface that allows a close approach
and optimal ªreadoutº of the antigenic peptide se-
quence. The a chain of the TCR interacts with the
N-terminal region of the SIYR peptide, while the b chain
is largely responsible for contacts at the C-terminal end
(Figure 2). As previously seen (Garboczi et al., 1996;
Ding et al., 1998; Garcia et al., 1998; Teng et al., 1998),
the a chain of the TCR dominates the number of interac-
tions to its pMHC antigens (48 out of 71 total contacts),
while the b chain interaction varies considerably in posi-
tion and extent of contact depending on the TCR and
pMHC (Garcia et al., 1999; Reinherz et al., 1999; Wilson,
1999). However, in the SIYR complex, the central CDRs
3a and 3b are even more dominant in interactions with
the peptide through 23 van der Waals contacts and 8
polar interactions (compared to 13 and 8, respectively,
for dEV8).
The conformation of the bound SIYR peptide itself is
substantially similar to dEV8 with an rms deviation of
0.70 AÊ for the Ca atoms (Figure 3A). However, a signifi-
cantly different conformation is seen for the side chain
of the basic residue at P4, where the alkyl moieties of
the two amino acids assume different orientations. The
ArgP4 in SIYR now makes contacts with the CDR3b of
2C through a specific hydrogen bond of the guanidinium
moiety (NH1) with the main chain carbonyl group of
Ser93a of the TCR; in dEV8, LysP4 contacts only CDR3a
(Figure 4). A slight rearrangement of the main chain at
the SerP1 position of SIYR, probably a consequence of
the IleP2 anchor residue being buried more deeply than
the corresponding Asn of dEV8, results in a more pro-
nounced protrusion of SerP1 toward the TCR (average
displacement for the main chain atoms 0.7 AÊ ), but still
not sufficient to make direct contact with the a chain
CDRs. TyrP6 is common to both SIYR and dEV8 and is
only slightly altered in the two complexes (Figures 3A
and 4B).
A key question is whether antigens that cause qualita-
tively different signals in the T cell have distinct effects
on the TCR conformation. The SIYR peptide is the
strongest agonist known to date (EC50 z10 pM) in any
TCR/pMHC system, whereas the dEV8 peptide is only
Figure 1. Affinity and Stability of the Different pMHC Ligands for a weak agonist (EC50 1 mM), yet their ternary complexthe 2C TCR
structures show marked similarity, with an rms deviation
(A) The 3D9 2C hybridoma was stimulated by immobilized H-2Kb of 0.92 AÊ for all Ca atoms. The relative orientation of theirmolecules and increasing concentrations of peptides.
membrane-proximal constant domains to the variable(B) Evaluation of TCR-ligand interaction by surface plasmon reso-
ones is only slightly altered with respect to the unli-nance and calculation of equilibrium dissociation constants using
ganded TCR (Garcia et al., 1996). Hence, no gross struc-a Scatchard analysis.
(C) Stability of the various TCR-pMHC complexes was tested by tural changes are transmitted to the TCR/pMHC on bind-
native gel assay. Only the Kb-SIYR complex shows a significant shift ing the superagonist ligand, as has also been observed
(asterisk) when added to 2C TCR. in a series of antagonist TCR/pMHC complexes (Ding
et al., 1999). However, the small shifts in the positions
Immunity
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Table 2. Peptide antigens for the 2C TCR
Peptide Sequencea Activity EC50 (mM)b Kd (mM)c Kd (mM)d Kass (M21s21103)d Kdiss (s211022)d t1/2 (s)
Kb-SIYR SIYRYYGL Super Agonist 0.00001 54 31.9 6 6.2 2.35 6 0.85 7.5 6 2.1 9.2
Kb-dEV8 EQYKFYSV Agonist 1 83 84.1 6 12.0 2.2 6 0.45 18.5 6 2.0 3.7
Kb-EVSV RGYVYQEL Antagonist 10 Ð 11.1 Ð Ð Ð
Kb-p2CA LSPFPFDL Weak Agonist 10 149 Ð Ð Ð Ð
Ld-p2CA LSPFPFDL Agonist 0.1 Ð 3.3 6 0.4 8.30 6 1.45 2.7 6 0.4 25.7
a The residues contacting the 2C TCR as observed from the crystal structures and from molecular modeling for the EVSV peptide are highlighted
in bold. The residues of the EVSV peptide that contact 2C, modeled by substituting the corresponding side chains in the 2C/Kb/SIYR complex,
are also highlighted. A model of the 2C/Ld/p2CA has been previously discussed (Speir et al., 1998).
b Concentration of peptide antigen at which half-maximal lysis of target cells is achieved (Sykulev et al., 1998).
c Values derived from the equilibrium measurements in Figure 1B.
d Values reported previously from the association and dissociation rates of soluble molecules measured by surface plasmon resonance (Garcia
et al., 1997). The values for the EVSV peptide have been obtained in a competition assay of 2C/anti-2C Fab9 binding on live cells by soluble
Kb/peptide complexes (Sykulev et al., 1998). t1/2 is the half-life of the TCR-pMHC complex.
of the constant domains may play a role in the transmis- through both a hinged movement and a minor main
chain conformational shift (Figure 3B). This rearrange-sion of binding to CD3 activation. Subtle structural shifts
have been correlated with receptor activation in other ment promotes the formation of several potential hydro-
gen bonds between the guanidinium group of the ArgP4systems, such as the aspartate receptor (Ottemann et
al., 1999) and the main chain carbonyl of residues b97 (3.7 AÊ ),
a93 (2.5 AÊ ), a99 (2.7 AÊ ), a101 (3.1 AÊ ) and the sideOn the other hand, small but important structural dif-
ferences arise at the receptor/ligand interface, where chain hydroxyl of Ser93a (3.2 AÊ ) (Figure 4B). The other
CDR loops (Figure 3B) are either unaltered or undergothe tip of the glycine-rich CDR3b loop is shifted by 1.7 AÊ
Figure 2. Structure of a TCR/MHC/Superag-
onist Complex
(A) Overall backbone structure of the 2C-Kb-
SIYR structure. The 2C TCR is on the top, the
a chain is colored pink, and the b chain is
colored light blue. The murine class I MHC
molecule H-2Kb is on the bottom, colored
green, with the noncovalently associated b2-
microglobulin in darker green. The superago-
nist SIYR peptide is in yellow. The CDR loops
of the TCR are color coded (1a, blue; 2a, pur-
ple; 3a, green; 1b, light blue; 2b, pink; 3b,
yellow; HV4, orange).
(B) Superposition of the 2C-Kb-SIYR complex
(yellow) with the 2C-Kb-dEV8 complex (gray).
Figure produced with MidasPlus2.0 (Ferrin et
al., 1988).
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tions, which would provide a more representative envi-
ronmental analogy to the amplifications occurring on the
cell surface. Do we then see interface complementarity
changes that can explain the dramatic differences in
bioactivity of SIYR versus dEV8?
Analysis of the TCR/pMHC interaction surfaces offers
a rationale for the different potency of the dEV8 and
SIYR peptides. The dEV8 peptide contacts the 2C TCR
directly through its side chains at positions P4, P6, and
P7 and through water molecules at P1 and P2 and con-
tributes approximately 240 AÊ 2 to the total buried surface
(985 AÊ 2) upon complex formation. For the SIYR peptide,
ArgP4 and TyrP6 mediate all of the side chain contacts
between 2C and peptide (Figure 4B) with the peptide
buried surface being 230 AÊ 2 out of 962 AÊ 2. As TyrP6 is
conserved between the dEV8 and SIYR peptides, the
P4 Lys!Arg mutation must be responsible for con-
verting the weak agonist into a superagonist. In 8-mer
peptides bound to Kb, this P4 position is a primary TCR
contact residue, with its side chain inserting into a deep
pocket of the TCR, between the CDR3a and b, which
is primarily lined by main chain atoms and side chains
that are largely neutral in character. Interestingly, the
longer guanidinium group makes similar hydrogen
bonds and polar contacts from its NH1 as the Lys-Nz
to the CDR3a backbone carbonyls of Ser93a (2.5 AÊ ver-
sus 2.4 AÊ ), Gly99a (2.7 AÊ versus 2.8 AÊ ), and Ala101a
(3.0 AÊ versus 3.5 AÊ ), but acquires new hydrogen bonding
Figure 3. Comparison of the Peptide Conformation and TCR CDRs possibilities with the side chain hydroxyl of Ser93a
between the Superagonist and Weak Agonist Peptide Complexes
(3.2 AÊ ) and the backbone carbonyl of Gly97b (3.7 AÊ ).
(A) Superposition of the dEV8 and SIYR peptides as observed in In addition, the guanidinium group is partially stacked
the structures of the 2C/Kb-dEV8 and 2C/Kb-SIYR complexes. The
against the CDR1b phenolic ring of Tyr31a, which isdEV8 peptide is colored green, and SIYR is colored orange. The
rotated toward it with respect to the conformation inmain chain is depicted as a Ca tube, and all the side chain atoms
are shown. The side chains of Lys and Arg at the P4 position have the dEV8 complex, and would provide some additional
different conformations, but the Nz and NH1 nitrogens are posi- stabilization for this complex (Figure 4B). The other pri-
tioned closely. mary TCR contact residue at P6 is accommodated in a
(B) Superposition of TCR 2C molecules from the 2C-Kb-SIYR com- cavity that is lined by the glycine-rich tip of CDR3b
plex, the 2C-Kb-dEV8 complex, and native 2C structure. The CDR
and CDR1b residues Asn30b and Asn31b. In SIYR, theloops are color coded as in Figure 1, with the native 2C loops the
aromatic ring of TyrP6 makes extensive contacts withdarkest and the dEV8 loops the lightest.
Gly96b and Gly97b main chain atoms, whereas its phe-
nolic hydroxyl hydrogen bonds to the side chain amide
oxygen and main chain nitrogen of Asn30b (2.7 AÊ andsmall rigid-body movements that are within the coordi-
3.4 AÊ , respectively). Thus, the outcome of the small con-nate error value. Thus, the structure of the same TCR
formational adjustment of the CDR3b loop in the SIYRin complex with two pMHCs that differ only in their bound
structure is to provide a tighter fit of P6 into the pocketpeptides demonstrates how small rearrangements of the
between CDR3b and CDR1b (Figure 4B).CDR loops can facilitate interaction with the same TCR
with different ligands, as previously proposed (Garcia
et al., 1998). However, what is most notable is that these
Shape Complementarity in the TCR/pMHC Interfaceremarkably subtle structural changes lead to dramatic
Analysis of the molecular surface of the TCR and pMHCdifferences in biological potency. In the human TCR
molecules underlines how 2C achieves better surfaceagonist and antagonist structures, a correlation was ob-
complementarity with the superagonist ligand, despiteserved between TCR affinity and antagonism (Ding et
a smaller number of total contacts (93 in dEV8 versusal., 1999). The antagonists demonstrated reduced affini-
71 in SIYR) and buried surface (985 AÊ 2 versus 962 AÊ 2).ties for TCR, and this manifested itself in poorer shape
We calculated the surface complementarity parameterscomplementarity and empty spaces in the TCR/pMHC
of the dEV8 and the SIYR complexes to be 0.464 andinterface, consistent with the measurements. In the 2C
0.471, respectively (Connolly, 1983; Lawrence and Col-system we describe here, the agonist activities of the
man, 1993). Although the value for the SIYR complex isSIYR versus dEV8 peptide ligands are profoundly differ-
somewhat larger, the very small difference in the overallent and do not correlate well with the equilibrium disso-
surface complementarities at first sight seems to indi-ciation constant and only weakly with kinetic binding
cate that no preferential binding of the TCR to the SIYR/measurements and half-lives of the soluble TCR and
MHC occurs. This conclusion is also inferred from thepMHC (Table 2). Instead, a better correlation is noted
with native gel band shifting at high protein concentra- only small differences in affinities of the TCR to the
Immunity
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Figure 4. The Binding Interface of the dEV8 and SIYR Peptides in Their Respective 2C/Kb Complexes
(A) Comparison of the dEV8 (left) and SIYR (right) complexes. The Va (pink), Vb (light blue), and MHC helices and floor (green) are shown as
ribbons. All atoms of the peptides are shown, with atoms colored according to atom type.
(B) Stereoview of the environment surrounding the P4 and P6 residues of SIYR (top) and dEV8 (bottom). The MHC molecules are in green
and the TCR a and b chains are in pink and light blue, respectively. Peptide atoms are colored according to atom type. Hydrogen bonds are
depicted as red dotted lines, while contacts between polar atoms not satisfying ideal hydrogen bonding geometry are shown as black dotted
lines.
pMHC complexes (Table 2). However, upon closer in- contact with the TCR, whereas the flanking residues at
the ends of the peptide must ªreach upº to contactspection of the interfaces, the highest degree of comple-
mentarity is achieved precisely at the central portion of the TCR. Modification of 2C peptide antigens at these
centrally located positions have maximal effects on bio-the contact surface between the P4 (9 versus 15 con-
tacts) and P6 (13 versus 16) residues of the pMHC mole- logical activity, while mutations at the N- and C-terminal
ends have markedly minor effects (Udaka et al., 1996;cule and the TCR cavities (Figure 5). This complementar-
ity matching could be due to the convex surface of the Sykulev et al., 1998). Indeed, direct and water-mediated
contacts at the P7 (Ser!Gly) and P1 (Glu!Ser) posi-pMHC contacting the relatively flat surface of the TCR
combining site; the central residues of the peptide at tions, respectively, have been lost in the SIYR complex.
Thus, the surface complementarity coefficient is a lessthe highest point of the curvature can achieve extensive
Crystal Structure of a TCR Superagonist Complex
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Figure 5. Surface Complementarity at the
TCR/pMHC Interface
The left side shows the 2C/Kb-dEV8 complex,
and the right side shows the 2C/Kb-SIYR. The
top panel displays the combining site of the
2C TCR viewed from the CDR loops, which
are color coded as in figure 2. The second
panel illustrates the molecular surface of the
TCR combining site, colored according to
surface complementarity with higher Sc val-
ues corresponding to yellow areas. Note the
surface pocket between the CDR3 loops of
the a and b chains and the greater degree of
complementarity for the SIYR antigen. The
third panel depicts the molecular surface of
the Kb/peptide complex, colored as in the pre-
vious panel. In both complexes, 2C achieves
similar complementarity with the MHC heli-
ces but has a significantly different fit around
the peptide P4 and P6 residues. The bottom
panel shows the backbone structure of the
H-2Kb molecule, with the antigenic peptides
in yellow and the TCR-directed side chains
colored in red. Figure produced with GRASP
(Nicholls et al., 1991).
valuable measure of function for interactions that de- bonding or van der Waals capabilities at these two key
positions then can obtain the subtle increases in kineticpend on only a few residues in the interface.
This notion is corroborated by the observation that, half-life that enhance either oligomerization of TCR/
pMHC complexes (Reich et al., 1997) and/or clusteringin the recently reported human agonist complex A6-
TCR/TAX/HLA-A2 (Ding et al., 1999), the surface com- of cosignaling or costimulatory molecules for initiation
of the intracellular signaling cascade (Grakoui et al.,plementarity coefficient is 0.645, whereas it is 0.667 for
the weak agonist complex A6-TCR/TAX(V7R)/HLA-A2. 1999). This conclusion is consistent with prior immuno-
logical observations from several other TCR/pMHC sys-Again, only small differences in the overall surface com-
plementarity accompany small differences in affinity, tems that centrally located peptide residues are the ma-
jor determinants of T cell activation (Evavold et al., 1992;whereas the more drastic differences in the biological
signaling are found to be brought about in a more subtle Ausubel et al., 1996; Kersh and Allen, 1996; Ghendler
et al., 1998).way (see below). Hence, the two central pockets in the
2C TCR surface encode for the fine specificity in the It is instructive to examine computationally (Laskow-
ski, 1995) the volume of significant gaps within the TCR/recognition of agonist and antagonist antigens and con-
stitute a functional hot spot for TCR/pMHC interaction. pMHC interfaces of both weak and superagonist com-
plexes (Figure 5) and to compare them with their coun-Peptides whose primary sequence contains residues
that achieve a more optimal fit and increased hydrogen terparts in the human antagonist complexes (Ding et
Immunity
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al., 1999). Two cavities close to the P4 residue change characterized by low affinity and high off-rates, and the
equilibrium binding constants of Kb/dEV8 and Kb/SIYRsignificantly in size when replacing the lysine (dEV8) with
to 2C are very similar, differing only by a factor of 1.3,an arginine (SIYR) (Figure 5). While the cavity between
although their half-lives do differ by a factor of 3 (TableP1 and P4 (left of P4 in Figure 5) enlarges from 82 AÊ 3 to
2). Recent direct thermodynamic measurements of TCR/187 AÊ 3, the cavity between P4 and P6 (right of P4 in
pMHC interactions support the concept of functionalFigure 5) shrinks from 234 AÊ 3 to 121 AÊ 3. The net result
complementation through a discriminatory entropic ad-is no change in cavity volume near the P4 residue when
aptation to ligand (Boniface et al., 1999; Willcox et al.,comparing the two complexes. Additionally, a small cav-
1999). The overall free energy of binding of TCR to pMHCity near the P6 residue in the dEV8 complex (33 AÊ 3) is
has been determined to be entropically unfavorable andsmaller in the SIYR complex (8 AÊ 3). Thus, the large, un-
interpreted as a conformational adjustment of the TCRfilled cavities present in the dEV8 and SIYR complexes
CDR loops to the pMHC surface, as previously noted indo not obviously correlate with their respective biologi-
the 2C/H-2Kb/dEV8 crystal structure (Garcia et al., 1998).cal activities. In the structures of the human TCR antago-
All of the pMHC ligands tested displayed this same prop-nist complexes, a loss of TCR/pMHC interface comple-
erty, implying an ªentropic differentiationº of ligand bymentarity, as evidenced by larger gaps in the interface,
the TCR. Clearly, the conformational adaptation influ-correlated more closely with the decreased affinity and
ences the ªspecificityº of the recognition of ligands bysignaling capabilities of the ligands (Ding et al., 1999).
the TCR, and so the shape and chemical properties ofInterestingly, between the two dEV8 and SIYR murine
the functional pockets in the TCR could change de-complexes, the sizes and shapes of the gaps between
pending on the ligand. This hypothesis could be testedTCR and pMHC vary in subtle ways, yet the bioactivity
by synthesizing peptide ligands that have approximatelydifferences are more dramatic than in the human com-
the same number of degrees of freedom as the agonistplexes. So, fewer structural changes result in a larger
or antagonist peptides, e.g., ornithine substituting forsignaling effect in this system.
lysine at P4 in dEV8 or citrulline substituting for arginineA recently reported peptide with antagonist activity
in SIYR. If entropic differentiation is used by the TCR tofor the 2C TCR derived from the vesicular stomatitis
determine the specificity of the recognition process,virus epitope (Sykulev et al., 1998), termed EVSV (RGY-
then the peptides should only differ in their biologicalVYQEL), does not have residues at either the P4 or P6
potency, not in their thermodynamic or kinetic proper-position that are homologous to the corresponding ones
ties. Thus, the induced fit in the TCR by different pMHCin either SIYR or dEV8 (Figure 1). Interestingly, this an-
ligands provides a mechanism that could be utilized totagonist has a higher affinity for the 2C TCR than a weak
transduce different signaling outcomes in the face ofagonist when measured on live cells (Sykulev et al.,
similar equilibrium constants.1998), which clearly implies that functional complemen-
Alanine-scanning mutagenesis of the 2C CDR loopstation of critical patches of the TCR combining site is
has shown that the entire TCR/pMHC contact surfacemore important to biological outcome than the simple
contributes relatively homogeneously to the binding en-energetic measurements that come from bimolecular
ergy, and only mutations that affect the TCR/MHC inter-interactions (Figure 1). Modeling of the EVSV sequence
face have major functional effects in the recognition ofin the 2C/Kb/SIYR structure supports the idea that this
the alloantigen H-2Ld/QL9 (Manning et al., 1998). Hence,peptide achieves nonoptimal contacts in the TCR func-
the functional hot spot must play a central role in de-tional hot spot. The valine residue at position P4 of
termining the complex half-life. In H-2Kb, the P4 and P6EVSV would result in a largely unfilled cavity between
residues are the only residues that can make substantialthe CDR3s of the a and b chain, and the glutamine at
contact with the TCR upon ligation (Garcia et al., 1998);P6 does not adequately complement the other cavity
poor chemical and steric complementarity of these resi-between CDR3b and 1b. The arginine and glutamic acid
dues to the TCR pockets would then result in shorter
residues at P1 and P7, respectively, could however pro-
half-lives of the ternary complex (Table 2). On the other
vide additional long-range electrostatic complementar-
hand, the strength of the biological signal could be in-
ity over their agonist counterparts. Similar behavior has creased even with low-affinity interactions by aggrega-
been observed for class II MHC-restricted TCRs; for tion of TCR/pMHC on the surface of the cell membrane.
instance, in the well-studied murine 3.L2 TCR recogni- This chemical compartmentalization of the TCR/pMHC
tion of the hemoglobin (64±76)/I-Ek antigen, replacement with the signal transducing components would then ac-
of the central primary TCR contact residue with natural count for the observed biological signal and hence
and nonnatural amino acids showed that smaller side would not be adequately represented by the thermody-
chains convert the agonist to an antagonist ligand (Kersh namics of the interaction, as measured by surface plas-
and Allen, 1996). mon resonance or in solution. Similar large differential
effects in signaling between agonist and weak agonist
Discussion and antagonist ligands have been noted for the EPO
receptor (Livnah et al., 1996, 1998; Syed et al., 1998;
One important consideration now emerging both from Wilson and Jolliffe, 1999).
the affinity measurements and structural analysis is that As hormone and cytokine receptors need to interact
the functional hot spot in the TCR combining site is with a single or limited number of physiologically rele-
probably not an enthalpic or entropic ªtrapº for the li- vant ligands, high affinity and specificity characterize
gand, as the bioactivity does not correlate well with the these types of interactions. The growth hormone (Clack-
equilibrium dissociation constant of the receptor/ligand son and Wells, 1995; Wells, 1996) and erythropoietin
receptors (Livnah et al., 1996; Syed et al., 1998) arecomplex. Instead, most TCR/pMHC interactions are
Crystal Structure of a TCR Superagonist Complex
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Experimental Procedureswell-characterized examples of such systems. Their three-
dimensional structures show tightly packed, highly com-
Structure Determinationplementary interfaces featuring a small, central hy-
Crystals of the 2C/Kb/SIYR complex were obtained as previously
drophobic patch in the binding site that interacts with described (Garcia et al., 1997). Prior to data collection, the crystals
their respective hormone or hormone-mimetics and ac- were harvested in a buffer containing 200 mM Tris acetate, 100 mM
sodium chloride, 12% PEG 4000 (pH 7.2), and 22% ethylene glycolcounts for most of the binding energy. Hydrophilic side
as cryoprotectant. Crystals were cryocooled to 21708C in a nitrogenchains, which largely mediate the on-rate in the complex
stream. X-ray diffraction data were collected at beamline 9-1 offormation, surround this ªenergetic hot spot.º This ener-
the Stanford Synchrotron Radiation Laboratory on a 345 mm MAR
getic hot spot is not present in the TCR/pMHC system, Research imaging plate using a monochromatic wavelength of
because it would not permit fine sampling of a broad 0.98 AÊ . Images were processed, integrated, and scaled with DENZO
and SCALEPACK (Otwinowski and Minor, 1997). Intensities werespectrum of antigens with very small structural differ-
converted to amplitudes using TRUNCATE (CCP4, 1994). The 2C/ences and hence would interfere with thymic selection
Kb/SIYR crystals are nearly isomorphous with the previously re-of a broad T cell repertoire. A single TCR has to be able
ported 2C/Kb/dEV8 crystals (Garcia et al., 1997), in the orthorhombic
to recognize a variety of structurally different antigens in space group P21212. A high variability of the b axis length in different
the thymus and in the periphery and deliver intracellular crystals was observed, with differences up to 7 AÊ , probably due to
signals of appropriate intensity. In the case of TCR/ a slight, nonreproducible reorientation of the molecules in the lattice
upon cryocooling. Data combined from different 2C/Kb/SIYR crys-pMHC interaction, the unfilled cavities in their interface
tals thus have high merging R factors. The structure was determinedhave a crucial role in determining the biological outcome
by molecular replacement using the 2C/Kb/dEV8 complex as aby enabling interactions with numerous possible struc- search model (Protein Data Bank code 2CKB) with the program
tures of TCR-activating ligands. AMoRe (Navaza, 1994). The translation function for the second mole-
Autoimmune diseases are a direct consequence of cule in the asymmetric unit could be solved only after sharpening
the measured intensities with a B factor of 45.0 AÊ 2, clearly showingautoreactive T cells mediating tissue damage after un-
a difference in temperature factors between the two independentdesired activation by self-antigens. The molecular mim-
copies of the complex. Similar results were obtained when the indi-icry hypothesis suggests that autoimmune reactions
vidual Kb/dEV8 and 2C models were used for the search (data not
could be a secondary effect of an immune response to shown). The structure of the complex was refined by means of
foreign antigens that share a common motif with se- iterative cycles of torsion angle dynamics using a maximum likeli-
hood target function and either slow-cooling or constant tempera-lected self-antigens (Fujinami and Oldstone, 1985). Pri-
ture protocols with the program CNS (BruÈ nger et al., 1998) andmary sequence homology (WuÈ cherpfennig and Stro-
manual model adjustment. Initially, one temperature factor per do-minger, 1995) or antigenic surface similarity are major
main was assigned. Tight noncrystallographic symmetry restraints
factors in the peptides' ability to stimulate the same T with a force constant of 300 kcal/mol.AÊ 2 on all atoms were used
cell clones. The dEV8 and SIYR peptides can be envi- with the best results based on Rfree variation obtained by restraining
independently the variable and constant regions of the TCR mole-sioned as the selecting self-peptide and the immuno-
cules, the membrane-proximal domain of Kb, and the peptide-bind-genic foreign epitope, respectively; one TCR-contacting
ing domain of Kb. The temperature factors of NCS-related Kb mole-residue is in common (TyrP6), along with a basic (Lys/
cules were restrained to a sigma of 10 AÊ 2, while 40 AÊ 2 was used for
Arg) residue at P4, and is restricted by the same self- the TCR, a value determined based on the electron density correla-
MHC molecule Kb. However, the side chain at residue tion for the NCS-related TCR molecules after molecular replace-
P4 is sufficiently different to alter the chemical and steric ment. Bulk solvent correction with a flat model and anisotropic
correction were used throughout the refinement. The model wascharacteristics of the two surfaces, such that very differ-
rebuilt in 10% shake-omit maps (McRee, 1993) and sA-weightedent reactivities of the two pMHC antigens are observed
2Fo-Fc and Fo-Fc maps (Read, 1986) using the program O (Joneswith the 2C clone. The biological effect of what would
et al., 1991). Progress of the refinement was assessed monitoring
appear to be a conservative mutation at the P4 position continuously Rfree for cross-validation (BruÈ nger, 1992) and avoiding
could hardly have been predicted from inspection of the divergence between Rcrys and Rfree. In the last stage of refinement,
highly restrained individual temperature factors were refined,antigen primary sequence (Ghendler et al., 1998).
achieving a drop in Rcrys and Rfree of 1.5% and 1.2%, respectively.Hence, the overwhelming conclusion is that the func-
The final electron density maps show a highly disordered TCR intional hot spot in the TCR is extraordinarily sensitive to
one of the two independent copies in the asymmetric unit. The high
small changes in the centrally located side chains of the Wilson B factor derived from the diffraction intensities correlates
bound peptide through increased complementarity as well with the overall average temperature factor of the model. The
final R values are relatively high and most likely reflect the anisotropywell as accumulation of additional hydrogen bonds. In
of the diffraction data as well as the disorder of one of the TCRthe murine system that we describe here, minor struc-
molecules. Analysis of the final model with PROCHECK (Laskowskitural differences translate into an enormous enhance-
et al., 1993) shows 71% of the residues in the ªmost favoredº regions
ment in the biological response, whereas in the human of the Ramachandran plot, with no outliers. Mean coordinate error
system, where antagonist structures have been exam- was estimated from a cross-validated sA plot.
ined (Ding et al., 1999), equally minor chemical differ-
ences in the peptide antigens resulted in a diminution
Surface Complementarity
of the T cell response. This exquisite sensitivity provides For the calculation of surface complementarity coefficients, the pro-
the TCR signaling complex with a mechanism for fine- grams MS (Connolly, 1983) and SPACE (Lawrence and Colman,
1993) were used with a sphere radius of 1.7 AÊ , a distance cut-offtuning the biological response to highly similar pMHC
of 5 AÊ , and a bandwidth for excluding the perimeter of 1.5 AÊ . Forligands. What is perhaps most surprising is that these
calculation of gaps in the TCR/pMHC interface, the program SURF-subtle changes in the TCR/pMHC interface can be trans-
NET (Laskowski, 1995) was used with a minimum and maximum for
lated into different clustering events that occur on the gap spheres of 1.0 AÊ and 4.0 AÊ , respectively. The overall surface
surface of the T cell in the immunological synapse (Gra- complementarity has been used by others as a measure for affinity
(Jeffrey et al., 1993, 1995; Harel et al., 1995; Torigoe et al., 1995).koui et al., 1999).
Immunity
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Plate Stimulation Assay suite programs for protein crystallography. Acta Crystallogr. D Biol.
Crystallogr. 50, 760±763.Ninety-six-well plates were coated with 10 mg/ml empty H-2Kb mole-
cules at 48C overnight in PBS. After washing unbound H-2Kb, the Clackson, T., and Wells, J.A. (1995). A hot spot of binding energy
peptides (dissolved in PBS) were added at room temperature for 2 in a hormone-receptor interface. Science 267, 383±386.
hr. This time span is long enough to displace all the weakly bound Connolly, M.L. (1983). Analytical molecular surface calculation. J.
peptides derived from the insect cell media from the H-2Kb mole- Appl. Crystallogr. 16, 439±473.
cules (Jackson et al., 1992). After that, 3D9 hybridoma cells (gener-
Delaney, J.R., Sykulev, Y., Eisen, H.N., and Tonegawa, S. (1998).ous gift of Dr. Paul Gottlieb) were added at 5 3 105 cells per well
Differences in the level of expression of class I major histocompati-overnight, and supernatants were harvested and tested for IL-2
bility complex proteins on thymic epithelial and dendritic cells influ-production using IL-2-dependent NK cells. Proliferation of NK cells
ence the decision of immature thymocytes between positive andwas assessed by incorporation of tritiated thymidine at 24 hr. Each
negative selection. Proc. Natl. Acad. Sci. USA 95, 5235±5240.concentration of peptide was tested in triplicate, and their binding
Ding, Y.H., Smith, K.J., Garboczi, D.N., Utz, U., Biddison, W.E., andunder similar conditions was tested by native IEF.
Wiley, D.C. (1998). Two human T cell receptors bind in a similar
diagonal mode to the HLA-A2/Tax peptide complex using different
Surface Plasmon Resonance
TCR amino acids. Immunity 8, 403±411.
All plasmon resonance experiments were done on a BIAcore 2000
Ding, Y.H., Baker, B.M., Garboczi, D.N., Biddison, W.E., and Wiley,(BIAcore) in PBS at 258C. The coupling density was 1500 RU. Soluble
D.C. (1999). Four A6-TCR/peptide/HLA-A2 structures that generate2C TCR was coupled to the dextran layer of a CM5 biosensor chip
very different T cell signals are nearly identical. Immunity 11, 45±56.through the free cysteine of the b chain. Soluble H-2Kb molecules
Dustin, M.L., Ferguson, L.M., Chan, P.Y., Springer, T.A., and Golan,loaded with the appropriate peptide were injected sequentially at
D.E. (1996). Visualization of CD2 interaction with LFA-3 and determi-20, 10, 5, and 2.5 mM at 10 ml/min. Specific binding was obtained
nation of the two-dimensional dissociation constant for adhesionby subtracting each sensorgram with the trace obtained with irrele-
receptors in a contact area. J. Cell Biol. 132, 465±474.vant H-2Kb-SSYSSSSS complexes. The data were linearized by plot-
ting the amplitudes of the resonance signal divided by the free ligand Evavold, B.D., Williams, S.G., Hsu, B.L., Buus, S., and Allen, P.M.
(RU/mM) as a function of the amplitudes (RU). After linear fitting, Kd (1992). Complete dissection of the Hb(64±76) determinant using T
was calculated as the negative of the inverse of the slope of the helper 1, T helper 2 clones, and T cell hybridomas. J. Immunol. 148,
line. Data are representative of two experiments. Due to the low 347±353.
concentrations of soluble ligand used with respect to the Kd values Ferrin, T.E., Huang, C.C., Jarvis, L.E., and Langridge, R.J. (1988).
derived, the latter can only be viewed as estimates and not as The MIDAS display system. J. Mol. Graph. 6, 13±27.
exact measures of the affinity. The values obtained are, however, in
Fujinami, R.S., and Oldstone, M.B. (1985). Amino acid homologyagreement with kinetic studies (Garcia et al., 1997; Table 2), although
between the encephalitogenic site of myelin basic protein and virus:kinetic studies often overevaluate the values slightly (Kersh et al.,
mechanism for autoimmunity. Science 230, 1043±1045.1998).
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Native Gel
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